Search

Your search keyword '"Wiegand J."' showing total 713 results

Search Constraints

Start Over You searched for: Author "Wiegand J." Remove constraint Author: "Wiegand J."
713 results on '"Wiegand J."'

Search Results

2. Spin and reoccupation noise in a single quantum dot beyond the fluctuation-dissipation theorem

3. New characterization methods for micro-injection molded specimens in polymer material development.

6. Measurement of heavy-hole spin dephasing in (InGa)As quantum dots

8. Global multi-stakeholder endorsement of the MAFLD definition

10. Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease and type 2 diabetes

11. Diagnostik und Therapie der chronischen Hepatitis B und C

12. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD : an individual patient data meta-analysis

13. Implications of early respiratory support strategies on disease progression in critical COVID-19: a matched subanalysis of the prospective RISC-19-ICU cohort

14. Machine learning using the extreme gradient boosting (XGBoost) algorithm predicts 5-day delta of SOFA score at ICU admission in COVID-19 patients

15. Implications of early respiratory support strategies on disease progression in critical COVID-19: a matched subanalysis of the prospective RISC-19-ICU cohort

17. Patient-reported Outcomes before and during the COVID-19 Pandemic in Patients with locally advanced or metastatic non-small Cell Lung Cancer in Germany : Data from the prospective CRISP Registry Platform (AIO-TRK-0315)

23. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis

28. Strategies to manage hepatitis C virus (HCV) disease burden

29. The present and future disease burden of hepatitis C virus (HCV) infection with todayʼs treatment paradigm

30. Historical epidemiology of hepatitis C virus (HCV) in selected countries

40. Implementation of a national registry for patients with primary biliary cholangitis (PBC): the German PBC cohort

41. Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease - Data from the German Hepatitis C-Registry (DHC-R)

43. PNPLA3 and HSD17B13 gene variants exert opposite effects on fatty liver phenotypes: results from the FLAG cohort

45. Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resources

48. Cytotoxic CD4+ T cells in viral hepatitis

49. Eclipse: a platform for integrating development tools

Catalog

Books, media, physical & digital resources